Centene Corporation (CNC) exhibits 8.1% gross margins and -31.0% return on invested capital within Health Care (Medical Specialities), balanced against a 24.0x enterprise multiple and 6.7% implied options volatility.
Sustained 8.1% gross profitability converts into -4.4% operating margin and -31.0% ROIC, outpacing sector cost of capital.
ROIC: -31.0% // GM: 8.1%YoY revenue trajectory of +20.0% paired with 12.72% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +20.0% // FCF YLD: 12.72%Altman Z-Score of 2.52 and Piotroski F-Score of 6/9 indicate low near-term refinancing stress.
ALTMAN Z: 2.52 // F-SCORE: 6/9Trading at 24.0x trailing P/E (36.0x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 24.0x // EV/EBITDA: —Options market prices a ±6.7% implied move with a 0.80 put/call ratio around $67.00 max pain.
IMPL MOVE: ±6.7% // P/C: 0.80Elevated industry capital intensity and customer concentration in Medical Specialities require continuous execution to defend -3.8% net margins.
NET MARGIN: -3.8% // D/E: 0.87x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for CNC & activate live FRED threshold breach alerts.